Jan. 18 (Bloomberg) -- Shares of the following companies had unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York.
Alexza Pharmaceuticals Inc. (ALXA US) had the second-biggest decline in the Russell 2000 Index, sinking 14 percent to $1.43. The Mountain View, California-based company said it plans to resubmit a new drug application for its AZ-004, a treatment of agitation in schizophrenia or bipolar disorder patients, and may face a vote by an advisory committee.
Apple Inc. (AAPL US) slumped 2.3 percent, the most since Nov. 12, to $340.65. Chief Executive Officer Steve Jobs took a leave of absence as a rare form of cancer he’s battled since 2004 and a more recent liver transplant affected his health, a person with knowledge of the matter said.
Ariad Pharmaceuticals Inc. (ARIA US) surged 34 percent to $7.04, the highest price since Oct. 2005. The Cambridge, Massachusetts-based drugmaker said a study showed its drug for sarcomas helped slow the disease’s advance.
Arrow Electronics Inc. (ARW US) rose 7 percent to $37.53, the highest price since Jan. 2008. The distributor of electronic components was lifted to “buy” from “neutral” at Longbow Research.
Avago Technologies Ltd. (AVGO US) fell 4.3 percent, the most since Dec. 7, to $27.75 . The maker of semiconductor components announced the sale of 25 million shares by certain existing shareholders.
Boeing Co. (BA US) climbed 3.4 percent to $72.47 for the biggest advance in the Dow Jones Industrial Average. The Seattle-based maker of the 787 Dreamliner said that the airplane’s delay to the third quarter would have no material impact on the company’s financials. It would be the first flight for certification credit since Nov. 9, when a fire broke out on a test jet.
Titanium Metals Corp. (TIE US), a supplier of the lightweight metal to Boeing, had the fourth-biggest gain in the Standard & Poor’s 500 Index, rising 4.7 percent to $19.16.
Citigroup Inc. (C US) slumped 6.4 percent to $4.80 for the second-biggest retreat in the S&P 500 Index. The third-largest U.S. bank reported profit that was less than analysts estimated, as the firm posted $1.1 billion in charges related to tightening of the bank’s credit spreads. The New York-based company earned 4 cents a share, excluding certain items, missing the average analyst estimate by 48 percent.
Comerica Inc. (CMA US) declined 8.3 percent to $38.74 for the biggest loss in the S&P 500. The Dallas-based bank that posted annual profits throughout the financial crisis agreed to buy Houston-based lender Sterling Bancshares Inc. (SBIB US) for about $1.03 billion in stock. Sterling investors will receive 0.2365 Comerica shares for each share they own.
Sterling Bancshares rallied 16 percent to $8.93.
Convergys Corp. (CVG US) climbed 6.6 percent to $14.52, the highest price since October 2008. The operator of customer-service call centers was boosted to “outperform” from “neutral” by Robert W Baird & Co.
Delta Air Lines Inc. (DAL US) declined 8.2 percent to $11.70, the lowest price since Oct. 19. The world’s second-largest carrier posted fourth-quarter profit that trailed analysts’ estimates as higher fuel expenses hampered results. Profit excluding merger expenses and other one-time items was 19 cents a share. Thirteen analysts had an average estimate of 24 cents.
Ener1 Inc. (HEV US) surged 14 percent, the most since Nov. 5, to $4.20. The maker of electric-car batteries agreed to set up a joint venture with Wanxiang Group Co., China’s largest auto-parts maker, to producer battery systems in China.
McMoRan Exploration Co. (MMR US) fell 7.7 percent to $15.69, the lowest price since Dec. 16. The New Orleans-based oil producer said it expects daily production for 2011 to be 160 million cubic feet of natural gas equivalents per day, down 0.6 percent from last year.
Molex Inc. (MOLX US) rose 2.8 percent to $25.49, the highest price since Sept. 19. The maker of electrical components for cars was raised to “overweight” from “underweight” by JPMorgan Chase & Co.
Mylan Inc. (MYL US) rose 4.5 percent to $23.83, the highest price since March 2006. The generic-drug maker said its subsidiary, Mylan Pharmaceuticals Inc., has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Acarbose Tablets, a treatment used to treat type 2 diabetes.
Novo Nordisk A/S (NVO US) jumped 4.4 percent to $115.93, the highest price since at least 1981. The world’s biggest maker of insulin was added to Bank of America Corp.’s “Europe 1” list.
Nvidia Corp. (NVDA US) fell 2.4 percent, the most since Dec. 13, to $23.04. The maker of computer-graphics chips was cut to “market perform” from “outperform” at BMO Capital Markets.
Smith & Nephew Plc (SNN US) rose 3.7 percent to $56.83, the highest price since September 2008. Analysts at Sanford C. Bernstein raised the London-based orthopedics company’s rating to “market perform” from “underperform,” citing “sustained” reports of a possible takeover.
Total System Services Inc. (TSS US) rose the most in the S&P 500, gaining 6.3 percent to $17.45. The credit-card processor was boosted to “outperform” from “neutral” by Credit Suisse Group AG.
Vodafone Group Plc (VOD US) climbed 4.5 percent, the most since May 27, to $28.75. The world’s biggest mobile-phone company is cheap compared with its peers and it may be the “best way to play” Verizon Wireless’s introduction of the iPhone, Barron’s said.
To contact the editor responsible for this story: Nick Baker at firstname.lastname@example.org.